Clinical Trials
Inovio Ebola Vaccine Demonstrates Robust Immune Responses with Favorable...
Inovio Pharmaceuticals, Inc. announced preliminary results from the expanded stage of its phase I study, EBOV-001. The expanded study examined different regimens of its Ebola...
Clinical Trials
Cytori Receives FDA Approval for Burn Clinical Trial Related...
Cytori Therapeutics, Inc. announced that the U.S. FDA has approved an IDE for a pilot clinical trial to evaluate Cytori Cell Therapyâ„¢ in patients with...
Clinical Trials
Kiadis Pharma receives regulatory approval for next trials for...
Kiadis Pharma N.V. , a clinical stage biopharmaceutical company developing innovative T-cell immunotherapy treatments for blood cancers and inherited blood disorders announces that it has...
Clinical Trials
Selvita Announces First Patient Dosed in Phase I/II Clinical...
Selvita , a clinical stage drug discovery and development company focused on innovative medicines for patients with blood cancers, announced that the first patient was...
Clinical Trials
LEO Pharma announces positive results from phase 2b clinical...
LEO Pharma today announced positive results from a Phase 2b dose-ranging efficacy and safety study of tralokinumab in adult patients with moderate to severe atopic...
Clinical Trials
Inovio Reports New Positive Clinical Data on Vaccine Advances...
Inovio Pharmaceuticals, Inc. announced that Dr. David B. Weiner, Inovio’s co-founder, presented positive clinical data on Inovio’s DNA-based vaccines against MERS (GLS-5300) and Zika (GLS-5700)...
Clinical Trials
Delmar Pharmaceuticals announces dosing of first patient in Phase...
DelMar Pharmaceuticals, Inc , a biopharmaceutical company focused on the development and commercialization of new cancer therapies. Announced that patient dosing has...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.